FIELD: medicine.
SUBSTANCE: bischofite dosage form additionally contains ammonium salt of glycyrrhizic acid in the following proportions, wt %: standardised bischofite solution - 5-10; ammonium salt of glycyrrhizic acid - 0.1.
EFFECT: invention may be used for treating pyoinflammatory processes of mucosae and skin.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
PROLONGED LIQUID DOSAGE FORM OF BISCHOFITE | 2011 |
|
RU2455008C1 |
PREPARATION POLYKATAN | 2013 |
|
RU2505302C1 |
METHOD FOR BISCHOFITE PURIFICATION | 2007 |
|
RU2442593C2 |
BALNEOLOGICAL MEAN BASED ON CRYSTALLINE BISCHOFITE | 2015 |
|
RU2657570C2 |
IODINATED MAGNESIUM CHLORIDE | 2009 |
|
RU2417089C2 |
PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT FOR TREATMENT OF DISEASES OF MUSCULOSKELETAL SYSTEM | 2021 |
|
RU2814317C2 |
BIOLOGICALLY ACTIVE ADDITIVE IN CASE OF ULCEROUS AND INFLAMMATORY PROCESSES IN GASTRO-INTESTINAL TRACT AND METHOD FOR ITS OBTAINING | 2002 |
|
RU2214229C1 |
METHOD FOR TREATING PURULENT WOUNDS AND BURNS | 1998 |
|
RU2147435C1 |
VAGINAL SUPPOSITORIES POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANALGESIC, ANTIPRURITIC ACTION | 2019 |
|
RU2729647C1 |
METHOD FOR PRODUCTION OF POLYVINYL ALCOHOL AND MAGNESIUM OR CALCIUM CHLORIDES POLYHYDRATED COMPLEXES | 2003 |
|
RU2268712C2 |
Authors
Dates
2012-12-20—Published
2011-06-27—Filed